86
Views
1
CrossRef citations to date
0
Altmetric
Research Articles

Repurposing of Streptomyces antibiotics as adenosine deaminase inhibitors by pharmacophore modeling, docking, molecular dynamics, and in vitro studies

, , &
Pages 77-88 | Received 22 Sep 2019, Accepted 09 Jan 2020, Published online: 23 Jan 2020

Reference

  • Lupidi G, Marmocchi F, Venardi G, et al. Functional residues at the active site of bovine brain adenosine deaminase. IUBMB Life. 1997;43:1339–1352.
  • Brady TG, O'Connell W. A purification of adenosine deaminase from the superficial mucosa of calf intestine. Biochim Biophys Acta. 1962;62(2):216–229.
  • Cortés A, Gracia E, Moreno E, et al. Moonlighting adenosine deaminase: a target protein for drug development. Med Res Rev. 2015;35(1):85–125.
  • Dong RP, Kameoka J, Hegen M, et al. Characterization of adenosine deaminase binding to human CD26 on T cells and its biologic role in immune response. J Immunol. 1996;156(4):1349–1355.
  • Gracia E, Cortés A, Meana JJ, et al. Human adenosine deaminase as an allosteric modulator of human A1 adenosine receptor: abolishment of negative cooperativity for [3H](R)-pia binding to the caudate nucleus. J Neurochem. 2008;107(1):161–170.
  • Saura C, Ciruela F, Casadó V, et al. Adenosine deaminase interacts with A1 adenosine receptors in pig brain cortical membranes. J Neurochem. 2002;66(4):1675–1682.
  • Giblett ER, Anderson JE, Cohen F, et al. Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity. Lancet. 1972;2:1067–1069.
  • Flinn IW, Kopecky KJ, Foucar MK, et al. Long-term follow-up of remission duration, mortality, and second malignancies in hairy cell leukemia patients treated with pentostatin. Blood. 2000;96(9):2981–2986.
  • Law WR, Valli VE, Conlon BA. Therapeutic potential for transient inhibition of adenosine deaminase in systemic inflammatory response syndrome. Crit Care Med. 2003;31(5):1475–1481.
  • Kameoka J, Tanaka T, Nojima Y, et al. Direct association of adenosine deaminase with T cell activation antigen, CD26. Science. 1993;261(5120):466–469.
  • Franco R, Valenzuela A, Lluis C, et al. Enzymatic and extraenzymatic role of ecto-adenosine deaminase in lymphocytes. Immunol Rev. 1998;161(1):27–42.
  • Tian YH, Schfer T, Sckell A, et al. Adenosine deaminase inhibition attenuates reperfusion low flow and improves graft survival after rat liver transplantation 1. Transplantation. 2000;69(11):2277–2281.
  • Robert IG. Adenosine deaminase inhibitors: their role in chemotherapy and immunosuppression. Cancer Chemother Pharmacol. 1980;4(4):227–235.
  • Weisman MI, Caiolfa VR, Parola AH. Adenosine deaminase-complexing protein from bovine kidney. Isolation of two distinct subunits. J Biol Chem. 1988;263(11):5266–5270.
  • Dureja H, Kumar V, Gupta S, et al. Topochemical models for the prediction of lipophilicity of 1,3-disubstituted propan-2-one analogs. J Theor Comput Chem. 2007;6(3):435–448.
  • Wold S. Validation of QSAR’s. Quantitative Structure-Activity Relationships. Wiley Online Library; 1991. [cited 2020 Jan 13]. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1002/qsar.19910100302

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.